ArticleHuman vaccines & immunotherapeutics2022

Immunogenicity and safety of BNT162b2 mRNA COVID-19 vaccine in a subject affected by Shapiro's syndrome: A case report.

Lorenza Moscara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.